Français

Central Canada includes Manitoba, Nunavut and Saskatchewan!


Here in the Central Region for Crohn's and Colitis Canada, we have a strong community of volunteers, donors and sponsors, as well as an innovative team of researchers and health professionals. These people are the heart and soul of our organization, and there are so many exciting ways to get involved. Every community, large or small, has the potential to help us improve the lives of those affected by Crohn’s disease and ulcerative colitis, and bring us closer to finding cures.

Senior Director, Community Engagement

jcavarra@crohnsandcolitis.ca
416-920-5035 ext. 244

Development Coordinator, Manitoba
Darrah Horobetz

204-688-9076

Outside Manitoba: 1-866-856-8551 (toll free)
Manitoba Mailing Address
PO Box 58039 Bishop Grandin PO
Winnipeg MB R2M 2R6
R2M 2R6

Outside Saskatoon: 1-844-664-4420
Saskatchewan Mailing Address
P.O. Box 28074 RPO Westgate
Saskatoon, SK
S7N 5V8

Events

Speaker giving a presentation

The Mediterranean Diet for Crohn's and Colitis

Do you struggle to find a diet plan that suits your nutritional needs without triggering your symptoms of IBD? Are you looking to find out about a diet that may be beneficial for people with Crohn ...

 • 
Zoom (Virtual)
 • 
Speaker giving a presentation

Cancer Risks in Crohn's and Colitis

Cancer Risks in Crohn's and ColitisDate: February 7, 2024Time: 7:00 - 8:30 p.m. ET People living with inflammatory bowel disease (IBD) are at an increased risk of developing cancer ...

 • 
Zoom (Virtual)
 • 
Remember to bookmark this page.

Winnipeg Office

PO Box 58039 Bishop Grandin PO
Winnipeg Manitoba R2M 2R6

204-688-9076 1-866-856-8551

Search by Postal Code

News

Kyle, Nathaniel and Vanessa are here to inspire you to join us at the 2023 Gutsy Walk!

Kyle, Nathaniel and Vanessa are here to inspire you to join us at the 2023 Gutsy Walk!

Crohn’s and Colitis Canada Responds to Ontario’s Decision to Proceed with Non-Medical Switch Policy

Crohn’s and Colitis Canada Responds to Ontario’s Decision to Proceed with Non-Medical Switch Policy

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

 4 5 6 7 8 9 10 11 12 13